Verve Therapeutics Inc (NASDAQ: VERV): Is It A Buying Opportunity Again?

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.

Stocks Info

VERV belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Verve Therapeutics Inc is $556.25M. A total of 2.13 million shares were traded on the day, compared to an average of 1.51M shares.

In the most recent transaction, Dorval Allison sold 555 shares of VERV for 5.64 per share on Dec 02 ’24. After the transaction, the Chief Financial Officer now owns 5,380 company shares. In a previous transaction on May 14 ’24, Ashe Andrew D. bought 76,000 shares at 6.26 per share. VERV shares that the insider owns now total 342,509.

Among the insiders who sold shares, Nickerson Joan disposed of 1,514 shares on Apr 02 ’24 at a per-share price of $8.24. This resulted in the Chief Administrative Officer holding 8,659 shares of VERV after the transaction.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, VERV has a high of $19.34 and a low of $4.30.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. VERV’s latest balance sheet shows that the firm has $360.44M in Cash & Short Term Investments as of fiscal 2021. There were $1.96M in debt and $22.02M in liabilities at the time. Its Book Value Per Share was $6.01, while its Total Shareholder’s Equity was $357.35M.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for VERV is Buy with a score of 4.50.

Most Popular

Related Posts